Clinical trials
Observational Hypoparathyroidism trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 6 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 11 |
| Unknown status | 5 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aristotle University Of Thessaloniki | 4 |
| University of Aarhus | 4 |
| Fujian Medical University | 3 |
| Ascendis Pharma A/S | 2 |
| Hospices Civils de Lyon | 2 |
| IRCCS San Raffaele | 2 |
| Aix Marseille Université | 1 |
| Azienda Ospedaliero-Universitaria di Modena | 1 |
| Beijing Friendship Hospital | 1 |
| Bettina Mittendorfer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoparathyroidism | 42 |
| Pseudohypoparathyroidism | 6 |
| Hyperparathyroidism | 5 |
| Hypocalcemia | 5 |
| Thyroid Neoplasms | 5 |
| Thyroid Diseases | 3 |
| Bone Diseases, Metabolic | 2 |
| Calcium Metabolism Disorders | 2 |
| Osteoporosis | 2 |
| Parathyroid Diseases | 2 |
Trials
Showing 26 to 42 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.